Galli, Mattia
 Distribuzione geografica
Continente #
NA - Nord America 1.101
EU - Europa 714
AS - Asia 123
AF - Africa 19
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
Totale 1.969
Nazione #
US - Stati Uniti d'America 1.097
SE - Svezia 248
IT - Italia 155
IE - Irlanda 74
DE - Germania 71
CN - Cina 63
FR - Francia 49
PL - Polonia 28
IN - India 18
UA - Ucraina 16
FI - Finlandia 15
GB - Regno Unito 14
JP - Giappone 12
CI - Costa d'Avorio 9
CZ - Repubblica Ceca 9
ET - Etiopia 9
NL - Olanda 7
AU - Australia 6
BE - Belgio 6
IR - Iran 6
HK - Hong Kong 5
RU - Federazione Russa 4
TR - Turchia 4
AT - Austria 3
BG - Bulgaria 3
CA - Canada 3
CH - Svizzera 3
EU - Europa 3
ID - Indonesia 3
QA - Qatar 3
BR - Brasile 2
PT - Portogallo 2
SG - Singapore 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
ES - Italia 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
KR - Corea 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
MX - Messico 1
MY - Malesia 1
OM - Oman 1
SI - Slovenia 1
VN - Vietnam 1
Totale 1.969
Città #
Chandler 319
Ashburn 94
Dublin 73
New York 52
Milan 37
San Mateo 37
Princeton 35
Wilmington 31
Bremen 28
Warsaw 28
Beijing 27
Boston 27
Marseille 26
Rome 21
Fairfield 18
Redwood City 18
Cattolica 17
Woodbridge 15
Augusta 11
Helsinki 11
Dearborn 10
Abidjan 9
Jacksonville 9
Los Angeles 9
Pune 8
Seattle 8
Houston 7
Saint Louis 7
Brussels 6
Groningen 6
Washington 6
Ann Arbor 5
Leawood 5
Nanjing 5
Andover 4
Cambridge 4
Catania 4
Guangzhou 4
Hollywood 4
Karlsruhe 4
Lappeenranta 4
Osimo 4
Palermo 4
Bari 3
Brno 3
Doha 3
Falls Church 3
Florence 3
Genoa 3
Genova 3
Istanbul 3
Jakarta 3
Kish 3
Mountain View 3
Perth 3
Sacramento 3
Shanghai 3
Sofia 3
Vienna 3
Boardman 2
Boydton 2
Busto Arsizio 2
Carlisle 2
Esslingen am Neckar 2
Fagnano Olona 2
Fremont 2
Fuzhou 2
Hangzhou 2
Hong Kong 2
Indaiatuba 2
Itamochi 2
Luoyang 2
Massa 2
Menlo Park 2
Millbury 2
Moscow 2
Nagasaki 2
Nanchang 2
Naples 2
Norwalk 2
Orbetello 2
Ottawa 2
Qingdao 2
Redmond 2
Romainville 2
San Diego 2
Scandicci 2
Stockholm 2
Taipei 2
Tianjin 2
Tokyo 2
Amsterdam 1
Axum 1
Bengaluru 1
Brest 1
Brisbane 1
Budapest 1
Casteggio 1
Chicago 1
Chisinau 1
Totale 1.182
Nome #
Ticagrelor and preconditioning in patients with stable coronary artery disease (TAPER-S): A randomized pilot clinical trial 165
Impact of coronary stenting on top of medical therapy and of inclusion of periprocedural infarctions on hard composite endpoints in patients with chronic coronary syndromes: a meta-analysis of randomized controlled trials 102
Coronary Atherosclerotic Phenotype and Plaque Healing in Patients with Recurrent Acute Coronary Syndromes Compared with Patients with Long-term Clinical Stability: An in Vivo Optical Coherence Tomography Study 100
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study 74
Coronary Atherosclerotic Phenotype and Plaque Healing in Patients with Recurrent Acute Coronary Syndromes Compared with Patients with Long-term Clinical Stability: An in Vivo Optical Coherence Tomography Study 68
Role of perilipin 2 in microvascular obstruction in patients with ST-elevation myocardial infarction 64
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study 61
Experience of Remote Cardiac Care during Covid-19 Pandemic: the V-LAP™ device in advanced heart failure 59
Sex-Related Differences in Dilated Cardiomyopathy with a Focus on Cardiac Dysfunction in Oncology 58
Intracoronary bolus of glycoprotein IIb/IIIa inhibitor as bridging or adjunctive strategy to oral P2Y12 inhibitor load in the modern setting of STEMI 56
Oral anticoagulants in fragile patients with percutaneous endoscopic gastrostomy and atrial fibrillation: the ORIGAMI pilot investigation 53
Dual quantitative coronary angiography accurately quantifies intracoronary thrombotic burden in patients with acute coronary syndrome: Comparison with optical coherence tomography imaging 51
Dropping aspirin in patients with atrial fibrillation undergoing percutaneous coronary intervention: A jump with a weak parachute? 51
Where Does Inflammation Fit? 51
Intracranial haemorrhages vs. stent thromboses with direct oral anticoagulant plus single antiplatelet agent or triple antithrombotic therapy: a meta-analysis of randomized trials in atrial fibrillation and percutaneous coronary intervention/acute coronary syndrome patients 50
Antithrombotic therapy in the early phase of non-ST-elevation acute coronary syndromes: A systematic review and meta-analysis 49
Neoatherosclerosis after drug-eluting stent implantation: A novel clinical and therapeutic challenge 48
Early anticoagulation in the current management of NSTE-ACS: Evidence, guidelines, practice and perspectives 48
Sustained safe and effective anticoagulation using Edoxaban via percutaneous endoscopic gastrostomy 47
Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: A pooled analysis underling possible safety concerns 47
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials 45
Efficacy and safety of dual pathway inhibition in patients with cardiovascular disease: a systematic review and Meta-analysis 43
How deep is your lesion? Extreme guideliner V3 intubation through RIMA graft to treat a distal left anterior descending artery stenosis 42
Double or triple antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention: Not a matter of faith 42
Telemedicine, Artificial Intelligence and Humanisation of Clinical Pathways in Heart Failure Management: Back to the Future and Beyond 41
Very short vs. long dual antiplatelet therapy after second generation drug-eluting stents in 35 785 patients undergoing percutaneous coronary interventions: a meta-analysis of randomized controlled trials 41
Role of perilipin 2 in microvascular obstruction in patients with ST-elevation myocardial infarction 39
Efficacy and safety of novel oral anticoagulants versus low molecular weight heparin in cancer patients with venous thromboembolism: A systematic review and meta-analysis 38
Do We Need to Define Therapeutic Ranges for Edoxaban Plasma Concentration? 37
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) with vs without left ventricular unloading by Impella: a systematic review and meta-analysis 34
Response - Letter to the editor: Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: A pooled analysis underlying possible safety concerns 34
Do We Need to Define Therapeutic Ranges for Edoxaban Plasma Concentration? 32
Adenosine as adjunctive therapy in acute coronary syndrome: a meta-analysis of randomized controlled trials 30
A 3-Year Single Center Experience With Left Atrial Pressure Remote Monitoring: The Long and Winding Road 27
Device-based remote monitoring strategies for congestion-guided management of patients with heart failure: a systematic review and meta-analysis 26
Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: A network meta-analysis 26
Comprehensive functional and anatomic assessment of myocardial bridging: Unlocking the Gordian Knot 24
Randomised trials and meta-analyses of double vs triple antithrombotic therapy for atrial fibrillation-ACS/PCI: A critical appraisal 24
Pre-stenting residual thrombotic volume assessed by dual quantitative coronary angiography predicts microvascular obstruction in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 23
Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations 20
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 18
Stent Thrombosis With Dual Antithrombotic Therapy in Atrial Fibrillation–ACS/PCI Trials 14
Gender-differences in antithrombotic therapy across the spectrum of ischemic heart disease: Time to tackle the Yentl syndrome? 12
Aspirin in primary prevention of cardiovascular disease in the elderly 5
Totale 2.019
Categoria #
all - tutte 9.582
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.582


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 1 0
2019/2020129 4 1 6 12 9 8 7 2 22 18 32 8
2020/2021181 7 9 7 6 16 46 22 9 6 15 31 7
2021/2022393 25 11 0 31 12 7 6 45 20 22 152 62
2022/2023921 102 108 65 143 47 124 56 80 136 10 29 21
2023/2024388 20 112 17 55 23 71 45 17 8 20 0 0
Totale 2.019